oral tirzepatide clinical trials Tirzepatide: What the Research Actually Shows Does Tirzepatide Show Up in

In one trial, individuals with calcium kidney stone disease and high urine calcium concentrations were instructed to increase their fluid intake to 23 L per day

There was not a significant difference in PASI, DLQI, or CRP in patients treated with liraglutide compared to controls

More recently, I have been getting a lot of questions about the difference between oral Wegovy (semaglutide) and a newly FDA-approved medication called Foundayo (orforglipron)

Additional trials of SYNERGY-NASH (NCT04166773) will look into tirzepatide's effectiveness in nonalcoholic steatohepatitis (NASH) and its effect on those who are obese and have heart failure with maintained ejection fractions

Cell Metabol 12(2):187193